0 التعليقات
0 المشاركات
1كيلو بايت مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Actinic Keratosis Treatment Market Set for Strong Growth Driven by Rising Skin CancerAccording to the latest report published by Data Bridge Market Research, the Actinic Keratosis Treatment Market CAGR Value The idea of this Actinic Keratosis Treatment Market research document is high level analysis of major market segments and recognition of opportunities in Actinic Keratosis Treatment Market industry. Experienced and innovative industry experts...0 التعليقات 0 المشاركات 985 مشاهدة 0 معاينة
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 التعليقات 0 المشاركات 4كيلو بايت مشاهدة 0 معاينة
-
Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...0 التعليقات 0 المشاركات 9كيلو بايت مشاهدة 0 معاينة
-
Global Cervical Cancer Therapeutics Market Future Growth ProspectsThe global cervical cancer therapeutics market size was valued at USD 6.33 billion in 2024 and is expected to grow from USD 6.61 billion in 2025 to reach USD 9.38 billion in 2033, growing at a CAGR of 4.47% during the forecast period (2025–2033). Key Highlights North America dominated the global cervical cancer therapeutics market and is expected to maintain its leading...0 التعليقات 0 المشاركات 3كيلو بايت مشاهدة 0 معاينة
-
Global Interventional Oncology Market Trends and Growth ForecastA speciality area of medicine called interventional oncology focuses on using minimally invasive, image-guided techniques to diagnose and treat cancer. It encompasses techniques such as tumor ablation, embolization, and targeted drug delivery, which allow physicians to treat cancerous tissues accurately while minimizing harm to surrounding healthy areas. These approaches offer significant...0 التعليقات 0 المشاركات 7كيلو بايت مشاهدة 0 معاينة
-
Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer PreventionAccording to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...0 التعليقات 0 المشاركات 4كيلو بايت مشاهدة 0 معاينة
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 التعليقات 0 المشاركات 7كيلو بايت مشاهدة 0 معاينة
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 التعليقات 0 المشاركات 3كيلو بايت مشاهدة 0 معاينة